Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03326674
Brief Title: Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (CONTESSA)

First Submitted : October 13, 2017
First Submitted that Met QC Criteria : October 25, 2017
First Posted : October 31, 2017

Last Update Submitted that Met QC Criteria : October 25, 2019
Last Update Posted : October 29, 2019